Equities

ECO Animal Health Group PLC

EAH:LSE

ECO Animal Health Group PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)110.50
  • Today's Change-0.50 / -0.45%
  • Shares traded65.43k
  • 1 Year change75.40%
  • Beta0.8198
Data delayed at least 20 minutes, as of Feb 06 2026 16:07 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year ECO Animal Health Group PLC had revenues fall -10.99% from 89.42m to 79.60m, though the company grew net income 60.88% from 1.05m to 1.69m.
Gross margin49.06%
Net profit margin5.95%
Operating margin7.74%
Return on assets4.52%
Return on equity3.62%
Return on investment5.78%
More ▼

Cash flow in GBPView more

In 2025, ECO Animal Health Group PLC increased its cash reserves by 11.76%, or 2.63m. The company earned 10.45m from its operations for a Cash Flow Margin of 13.13%. In addition the company used 4.61m on investing activities and also paid 1.95m in financing cash flows.
Cash flow per share0.1153
Price/Cash flow per share9.43
Book value per share1.25
Tangible book value per share0.6137
More ▼

Balance sheet in GBPView more

ECO Animal Health Group PLC has a Debt to Total Capital ratio of 5.20%, a higher figure than the previous year's 3.75%.
Current ratio3.73
Quick ratio2.75
Total debt/total equity0.0597
Total debt/total capital0.052
More ▼

Growth rates in GBP

Year on year, growth in earnings per share excluding extraordinary items increased 60.05%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)-15.21
EPS (TTM) vs
TTM 1 year ago		402.98
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.